News
AZ grabs FDA nod for Ultomiris in rare kidney disease IgAN
AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.
News
Roche posts solid results ahead of looming patent cliff
Roche's Q3 pharma sales rose a healthy 7%, although the first signs of weakness for blockbuster product Xolair are a warning of tougher times ahead.
News
Despite US policy changes, drug prices stay stubbornly high
US policy changes designed to curb drug prices seem ineffective, as the annual cost of new medicines still exceeds $250,000, curbing patient access.
News
ViiV's Waterhouse exits to take the CEO job at CSL
CSL has named Deborah Waterhouse as its new chief executive, on the same day her departure from the same role at ViiV was announced.
News
GSK wins FDA green light for chronic hep B treatment Hibsago
GSK's antisense-based drug for chronic hepatitis B virus (HBV) infection, Hibsago, has been approved in the US, its second major market after Japan.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
